---
category: news
title: "AI-designed drug to treat deadly disease now tested on humans"
excerpt: "The first phase of clinical trials testing an AI-designed drug to treat a chronic lung disease is now underway, according to biotech startup Insilico Medicine. Using deep learning to discover new drugs is a relatively fresh development in the pharmaceutical industry,"
publishedDateTime: 2022-02-25T17:53:00Z
originalUrl: "https://www.theregister.com/2022/02/24/ai_drug_humans/"
webUrl: "https://www.theregister.com/2022/02/24/ai_drug_humans/"
ampWebUrl: "https://www.theregister.com/AMP/2022/02/24/ai_drug_humans/"
cdnAmpWebUrl: "https://www-theregister-com.cdn.ampproject.org/c/s/www.theregister.com/AMP/2022/02/24/ai_drug_humans/"
type: article
quality: 57
heat: -1
published: false

provider:
  name: theregister
  domain: theregister.com

topics:
  - AI

images:
  - url: "https://regmedia.co.uk/2022/02/24/shutterstock_chemicals.jpg"
    width: 1200
    height: 627
    isCached: true

related:
  - title: "First Wholly AI-Developed Drug Enters Phase 1 Trials"
    excerpt: "Insilico Medicine today announces the start of the worldâ€™s first Phase 1 clinical trial of a drug developed from scratch using Artificial Intelligence (AI)."
    publishedDateTime: 2022-02-25T08:45:00Z
    webUrl: "https://www.forbes.com/sites/calumchace/2022/02/25/first-wholly-ai-developed-drug-enters-phase-1-trials/"
    ampWebUrl: "https://www.forbes.com/sites/calumchace/2022/02/25/first-wholly-ai-developed-drug-enters-phase-1-trials/amp/"
    cdnAmpWebUrl: "https://www-forbes-com.cdn.ampproject.org/c/s/www.forbes.com/sites/calumchace/2022/02/25/first-wholly-ai-developed-drug-enters-phase-1-trials/amp/"
    type: article
    provider:
      name: Forbes
      domain: forbes.com
    quality: 89
    images:
      - url: "https://imageio.forbes.com/specials-images/imageserve/621760b45515d81ae3ea4192/0x0.jpg?format=jpg&width=1200&fit=bounds"
        width: 1200
        height: 800
        isCached: true

secured: "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;IMxxGqEXYHP80/tTGJbpUQ=="
---

